文献速递主动脉疾病

九旬患者EVAR的风险与临床结局平衡

Balancing Risks and Clinical Outcomes of Endovascular Aneurysm Repair in Nonagenarians.
PubMed 文献 · Ann Vasc Surg · 2025-07-22

该回顾性研究分析了144例择期EVAR患者,其中九旬组12例、较年轻组132例,比较术后30天与1年结局。九旬组无早期或动脉瘤相关死亡,短期结局良好,1年生存率67%对较年轻组90%(P=0.116),但Kaplan-Meier总体生存曲线差异显著(P=0.012);临床衰弱评分≥6及吞咽困难或COPD与1年死亡显著相关。

要点

  • 九旬患者EVAR短期结局良好,无早期或动脉瘤相关死亡。
  • 九旬组1年生存率67%,较年轻组90%,差异未达显著(P=0.116)。
  • 临床衰弱评分≥6及吞咽困难或COPD与九旬患者1年死亡显著相关。

核心结论

  • 九旬患者EVAR短期结局良好,无早期或动脉瘤相关死亡,长期生存接近年龄性别匹配的日本一般人群。
  • 对严重衰弱或合并吞咽困难、呼吸功能损害等合并症者,应审慎考虑EVAR。

研究设计与样本

  • 回顾性分析2013年4月至2023年8月间144例择期EVAR患者,其中年龄<90岁132例、≥90岁12例。

主要发现

  • 30天动脉瘤相关死亡(P=0.840)、动脉瘤相关死亡率(P=0.769)及术后并发症(P=0.297)两组间无显著差异。
  • 1年生存率九旬组67%对较年轻组90%(P=0.116),但Kaplan-Meier总体生存曲线两组间差异显著(P=0.012)。
  • 九旬组4例术后1年内死亡,临床衰弱评分≥6(P=0.034)及吞咽困难或COPD(P=0.002)与1年死亡显著相关。
  • 九旬患者EVAR后生存与年龄性别匹配的日本一般人群相当。

临床怎么用

  • 九旬患者行EVAR需综合评估衰弱(临床衰弱评分≥6)及吞咽困难或COPD等合并症以辅助筛选。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endovascular aortic repair (EVAR) is a viable option for elderly patients with abdominal aortic aneurysm. In extremely elderly individuals with inherently limited survival, this study aimed to evaluate EVAR outcomes in nonagenarians and identify factors associated with favorable survival to refine selection criteria. METHODS: We retrospectively analyzed 144 patients who underwent elective EVAR between April 2013 and August 2023. Patients were divided into those aged <90 years (younger group, n = 132) and ≥90 years (nonagenarian group, n = 12). Primary outcomes included postoperative morbidity and mortality. In addition, we explored potential risk factors for early mortality in the nonagenarian group. RESULTS: There were no significant differences between the groups in 30-day (P = 0.840) aneurysm-related mortality (P = 0.769) or postoperative morbidity (P = 0.297). At 1 year, the survival rate was 67% in the nonagenarian group and 90% in the younger group (P = 0.116). While this difference was not significant, the overall Kaplan-Meier survival curve demonstrated a significant divergence between the two groups (P = 0.012). Four nonagenarians died within 1 year postoperatively. A Clinical Frailty Score ≥6 and the presence of dysphagia or chronic obstructive pulmonary disease were significantly associated with 1-year mortality (P = 0.034, 0.002). The survival of nonagenarians post-EVAR was comparable to an age- and sex-matched general Japanese population. CONCLUSION: EVAR in nonagenarians resulted in favorable short-term outcomes with no early or aneurysm-related deaths. Their long-term survival approximated that of the general population, suggesting EVAR may offer comparable prognostic benefit. However, in patients with severe frailty or comorbidities, such as dysphagia or respiratory impairment, EVAR should be carefully considered.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Natsume K, Saito Y, Miyahara S, et al. Balancing Risks and Clinical Outcomes of Endovascular Aneurysm Repair in Nonagenarians. Ann Vasc Surg. 2025. PMID: 40706848. doi:10.1016/j.avsg.2025.07.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。